October 2026

Medtronic recalls defibrillation leads | FDA approves PVL treatment | A 'remarkably bad' CMS policy | Heartflow sues Elucid ()
The world's best hospitals for cardiology & heart surgery | HFSA takes on right heart failure | CCTA on the go | Peripheral IVL ()
New CMS payment model is 'remarkably bad' | FDA confirms Class I recall for Impella controllers | Strokes after TAVR ()
Safety Updates: Medtronic recalls defibrillation leads | FDA shares warning about heart valve tech | Much more ()
FDA approves new device for PVL | Medtronic recall requires a software update | HFSA takes on right heart failure ()
The top hospitals for heart surgery | Surgeons now earn more than $1M per year | New valve for children is the first of its kind ()
AHA & others redefine women's heart health | Pulmonary hypertension research | Cannabis & hospitalizations | New LAAO tech ()
Defibrillation leads recalled | Heartflow sues Elucid | CCTA screening shows potential | Heart surgery performed on stage ()
Choosing PET over SPECT | Key M&A trends in cardiology | Rising healthcare costs | Surgical backup during TAVR: Is it necessary? ()
Week in Review: A new Class I recall | FDA approves oral semaglutide for CV benefits | ASE leads push to revise CPT code ()
Surgical backup during TAVR | What SCAI learned from its members | FDA clears AI-enabled stethoscopes | High-risk inflammation ()
Safety issues for Abbott & Edwards | Heart surgeons earn more than $1M per year | Coronary plaque imaging keeps improving ()
Planning ahead with CCTA | FDA impressed by resorbable scaffold for PCI | Hillary Clinton at STS meeting | Firefighter deaths ()
Why AI will not replace cardiologists | Improving imaging workflows | Reimbursement trends | Cardiology tech in the spotlight ()
FDA approves Edwards valve for T-TEER | TAVR vs. SAVR | Elucid's new AI software | Tracking a ‘catastrophic’ PCI complication ()
Expanding access to cardiac PET | J&J's new IVL catheter | AI flags patients at risk of decline | Transplant rejection warnings ()
Abbott highlights safety risk | Trends in coronary plaque imaging | ACC takes on exercise | FDA clears AFib tech | SCAI's survey ()
Abbott updates device instructions | New heart valve grows with children | FDA shares a warning | CMS may cover TAVR for AR ()
Why new pediatric valve is a breakthrough | FDA's warning after death | Heart surgeon compensation | AI for cardiology questions ()
Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled ()
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation ()
News Alert: FDA shares warning about heart valve tech after patient death ()
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval ()
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves ()
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart ()
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks ()
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR ()
TAVR accessories recalled | A new ultrasound strategy | Lab-grown graft delivers | Sutureless heart valves | Coverage concerns ()
News Alert: Siemens Healthineers doubles down on cardiovascular care as it exits general imaging ultrasound business ()
The best hospitals in the world for heart surgery | More momentum for AI-powered CCTA tools | Peripheral IVL vs. atherectomy ()
Top 10 most popular cardiology video interviews this past month ()
The world’s best heart hospitals | Why healthcare costs keep rising | CMS may cover TAVR for AR | New drug now under review ()
The consistent value of intravascular imaging | New LVAD data | The first procedure of its kind | Stroke robot impresses FDA ()
Why healthcare costs keep rising | HeartMate 3 LVAD linked to strokes, other risks | Supplement recalled | On-the-go CCTA scans ()
Previewing TCT 2026 | FDA clears new AI tool | First procedure of its kind performed in US | Intravascular imaging & PCI ()
The world's best heart hospitals | New CVD trends | Real-world thrombectomy data | AHA Scientific Sessions 2026 ()
TAVR Highlights: Medicare covers asymptomatic patients | More policy changes on the way? | AI's impact | The risk of waiting ()
New heart device makes US debut | CT-based extracellular volume assessments | Canon launches TAVR tech | Riverrain & RapidAI ()
Semaglutide & the heart | Pro athlete sues doctors | BP drug recalled | GLP-1 pill makes a difference | A new CVD risk factor ()
CMS may cover TAVR for aortic regurgitation | FDA approves CardioMEMS updates | Lilly's GLP-1 pill | Celebrating outpatient care ()
September's Top Stories: BP drug recalled | Major TAVR changes | AI for heart attack detection | FDA approves small pacemaker ()
Making cardiologists feel safer | New SCAD research | Young children on GLP-1s | Heart attack drug submitted to FDA ()
Cardiology compensation climbs again | FDA OKs first heart valve of its kind | AI improves workflows | Rural practices struggle ()
AI scans routine images to evaluate risk | Looking back at ESC Congress 2026 | New ASNC recommendations | Building a CT program ()
FDA clears heart valve that grows with pediatric patient | Renal denervation assigned CPT I codes | Regenerating heart cells ()
Improving workflows with AI | Expert insights on heart-healthy diets | Startup's big news | Video tech cleared for new surgeries ()